LEMULSA
DEAD

Serial Number

87650938

Owner

Lemulsa Technologies Inc.

Attorney

Nancy J. Flint, Esq.

Filing Date

Oct 18, 2017

Add to watchlist:

No watchlists yet
View on USPTO

LEMULSA Trademark

Serial Number: 87650938

LEMULSA is a trademark filed by Lemulsa Technologies Inc. on October 18, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Lemulsa Technologies Inc. (2 trademarks)

Suite A
Dover, DE 19803

Entity Type: 03

Trademark Details

Filing Date

October 18, 2017

Registration Date

Not Registered

Published for Opposition

May 14, 2019

Goods & Services

Drug delivery agents consisting of compounds that facilitate delivery of a wide range of prescription pharmaceuticals; Drug delivery agents in the form of a coating for tablets and capsules that facilitate the delivery of a wide range of prescription pharmaceuticals; Medicinal prescription preparations for viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations, namely, an oral preparation for the treatment of erectile dysfunction prescribed by medical doctors; Prescription pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Therapeutic prescription pharmaceutical for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Nutraceuticals for use as a dietary supplement; Medicated cosmetics

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 27, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 27, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 27, 2023 REAP
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Feb 10, 2020 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Feb 10, 2020 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 9, 2019 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 14, 2019 NPUB
PUBLISHED FOR OPPOSITION
May 14, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 24, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 4, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 4, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 4, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 4, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 4, 2019 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 19, 2018 GNRN
NON-FINAL ACTION E-MAILED
Sep 19, 2018 GNRT
NON-FINAL ACTION WRITTEN
Sep 19, 2018 CNRT
EXAMINER'S AMENDMENT ENTERED
Aug 23, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 23, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 23, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 23, 2018 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 2, 2018 GNRN
NON-FINAL ACTION E-MAILED
Feb 2, 2018 GNRT
NON-FINAL ACTION WRITTEN
Feb 2, 2018 CNRT
ASSIGNED TO EXAMINER
Jan 26, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 27, 2017 NWOS
NEW APPLICATION ENTERED
Oct 21, 2017 NWAP